DFMO Clinical Trials

5 actively recruiting trials across 5 locations

Also known as: Difluoromethylornithine, Eflornithine, α-difluoromethylornithine, difluoromethylornithine, eflornithine, iWilfin

Filter by location:

Birmingham, Alabama1 trial

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

University of Alabama/Children's of Alabama

Phase 2

Aurora, Colorado1 trial

TArgeting Type 1 Diabetes Using POLyamines (TADPOL)

Barbara Davis Center

Phase 2

Baltimore, Maryland1 trial

Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer

Johns Hopkins University: Sidney Kimmel Comprehensive Cancer Center

Phase 2

Lake Success, New York1 trial

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

START Cancer Research New York-Long Island

Phase 1/2

The Bronx, New York1 trial

DFMO Maintenance for Patients With Relapsed/Refractory Ewing Sarcoma or Osteosarcoma

Montefiore Medical Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.